A few changes

I said that I was looking to buy Slack, and this is now done. When I held the stock last year there was no pandemic – now the long term implications of working from home or from bubbles are sinking in.

On the medical and pharmaceutical front I sold my holdings in Gilead. This was bought because they had a treatment that helped patients with coronavirus. Several new treatments have emerged from studies, and I have the feeling that there will be more to come before any mass vaccination programmes, and that at least one of these will be preferred to the Gilead product. Another area of interest is telemedicine – where the level of take up this year has been massive. I have a few companies on my watch list here, and so far have bought Veeva Systems and Teladoc

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.